ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2025; 15(11): 5995-6008


Apoptotic role of RASSF6 in regulating PRV-infected porcine alveolar macrophages

Xianghua Shu, Yalong Sun, Shanqiang Wang, Dayong Yang, Xing Li, Ying Zhang, Chunlian Song.



Abstract
Download PDF Post

Background:
Pseudorabies virus (PRV), a zoonotic swine alphaherpesvirus, poses a severe threat to global pig production and public health.

Aim:
This study aimed to investigate the regulatory role of the RASSF6 gene in PRV-infected porcine alveolar macrophages (3D4/21).

Methods:
We established stable cellular models of RASSF6 overexpression (verified by qRT-PCR and immunofluorescence using an empty vector control) and siRNA-mediated RASSF6 silencing (verified by qRT-PCR) to investigate the role of RASSF6. Using these models, we assessed viral replication (quantified by qRT-PCR/TCID50) and apoptosis (analyzed by flow cytometry with Annexin V/PI staining and ELISA).

Results:
RASSF6 expression was significantly upregulated after PRV infection. RASSF6 overexpression inhibited 3D4/21 cell proliferation and PRV replication and promoted apoptosis through Bax and Caspase-3/9 activation. RASSF6 silencing promoted cell proliferation and viral replication and inhibited apoptosis.

Conclusion:
RASSF6 is a critical host defense factor against PRV infection in porcine alveolar macrophages. RASSF6 upregulation restricts viral replication by inducing apoptosis via Bax/caspase-3/9 activation and simultaneously suppressing cell proliferation. Conversely, RASSF6 silencing creates a permissive environment for PRV propagation by inhibiting apoptosis and enhancing cell survival. These findings reveal RASSF6-mediated apoptosis as a novel antiviral mechanism and highlight its potential as a therapeutic target for controlling PRV pathogenesis.

Key words: Apoptosis; Porcine alveolar macrophages; Pseudorabies virus; RASSF6.







Bibliomed Article Statistics

113
55
2
R
E
A
D
S

66

17


D
O
W
N
L
O
A
D
S
120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.